Business context and reporting period
Getty Images Holdings, Inc. filed this Form 8-K regarding events beginning September 29, 2026. This is an event filing, not a periodic financial report; it contains no current-period financial statements.
Key financial metrics and liquidity
The filing provides no revenue, profit, cash flow, margin, debt-balance, or liquidity figures. It says the Company and its advisers are evaluating strategic financing alternatives and balance-sheet management initiatives, with an active and progressing dialogue with key debt and equity holders.
Material developments
- The NYSE notified the Company that it would begin delisting proceedings because of “abnormally low selling price” levels and immediately suspended trading in the Class A common stock.
- The Company does not intend to appeal and expects the stock to be delisted. The NYSE will seek SEC delisting after applicable procedures; the filing says delisting becomes effective 10 days after the NYSE files Form 25.
- The stock began trading on the OTC Pink Limited Market under GETY on September 30, 2026. The Company says the market transition will not affect business operations, but gives no assurance that OTC trading or public quotes will continue or provide sufficient liquidity.
- The Board postponed the 2026 annual meeting, previously scheduled for October 8, 2026, in light of the financing and balance-sheet discussions and the delisting proceedings. No new meeting date is provided.
Outlook, risks and contingencies
The filing gives no financial guidance. It identifies substantial doubt about the Company’s ability to continue as a going concern as a risk previously expressed by the Company. Other cited risks include securing additional capital on commercially reasonable terms, implementing strategic alternatives, continued access to third-party content, customer retention and spending, competition, cost management, technology and cybersecurity, litigation, and volatility and reduced liquidity in the stock.
Most important facts to verify
- Whether the NYSE files Form 25 and when delisting becomes effective.
- Whether OTC trading and broker-dealer quotes continue, and the resulting trading volume and liquidity.
- Progress and outcomes of financing alternatives and balance-sheet initiatives, including any effect on debt holders and stockholders.
- Any update on the postponed annual meeting and the Company’s going-concern position.